Global Blood Glucose Devices Market Report (2022 to 2027) – Key Drivers and Challenges | News

0

DUBLIN , May 13, 2022 /PRNewswire/ — The report “Blood Glucose Devices Market, Global User Forecast 2022-2027, SMBG Components, Industry Trends, Growth, Overview, COVID-19 Impact, Business Analysis” has been added. to from ResearchAndMarkets.com offer.

The report provides a detailed analysis of the Blood Glucose Monitoring Devices industry. The Global Self-Monitoring Blood Glucose Monitoring Devices Market is Expected to Reach US$46.69 billion in 2027.

Over time, typical laboratory diagnostic tests have served only to help doctors diagnose the disease. Patients with more fluctuating blood sugar levels, on the other hand, need daily blood glucose monitoring. In addition, patients using insulin should monitor their blood sugar regularly. Therefore, a current approach to diabetes care involving blood glucose meters by patients to quickly check their glucose levels and provide an accurate assessment of capillary glucose concentration is known as self-monitoring blood glucose (SMBG). . Additionally, blood glucose monitoring helps diabetic patients make day-to-day management decisions such as food intake, insulin dosage, and physical activity.

Blood Glucose Monitoring Devices industry is expected to grow with a CAGR of 4.12% from 2021 to 2027:

The increased prevalence of diabetes is attributed to the growth in the market for self-monitoring blood sugar gadgets. Additionally, lifestyle changes, dietary choices, increased smoking and alcohol consumption are likely to increase diabetes prevalence rates. Again, as people become more aware of home monitoring and the importance of regular diabetes treatment to reduce the risk of hyperglycemia, the demand for self-monitoring glucometers is increasing.

In addition, the government is launching several public awareness programs on early diagnosis. The National Diabetes Education Program (NDEP) collaborated with the Centers for Disease Control and Prevention (CDC) and the NIH. The National Diabetes Education Program (NDEP) works to reduce the prevalence of prediabetes by providing diabetes education to an eclectic group of people, including hard-to-reach locals, faith communities, ethnic minorities , community organizations and health care providers.

Influence of COVID-19 on Blood Glucose Monitoring Devices Industry:

COVID-19 outbreak accelerated the growth of the Blood Glucose Monitoring Devices Market. Due to the pandemic, a few market participants have reported an increase in diabetes care revenue. For example, Abbott claimed in June 2020 that their FreeStyleLibre blood glucose monitoring device accounted for 59.3% of the company’s sales growth in the first quarter of 2020. With the increased risk of coronavirus transmission among diabetic patients, a new emphasis has been placed on the devices monitoring device for home use to help patients regulate their blood sugar levels. According to the publisher, the market for self-monitoring blood glucose devices was US$36.64 billion in 2021.

Global Blood Glucose Monitoring Devices Market Segmentation:

The self-monitoring blood glucose devices industry is categorized from the perspective of type 1 diabetes and type 2 diabetes for the diabetic population, the market for blood glucose devices (SMBG) (test strips, lancet, glucometer), blood glucose device users (SMBG) and reimbursement of blood glucose devices from 17 countries (United States, UK, Germany, Spain, Italy, Netherlands, Norway, Sweden, Swiss, Australia, Kuwait, Brazil, Russia, India, China, South Africaand Saudi Arabia)

Competitive Landscape:

The major global players in the self-monitoring of blood glucose market are Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG and DarioHealth Corp. According to the data, these companies are present in the global market and hold a significant portion of the market. At the same time, the remaining manufacturers are limited to other local or regional manufacturers. Recent mergers and acquisitions between the participants have helped the companies to strengthen their presence in the market.

Main topics covered:

1. Introduction

2. Research and methodology

3. Executive Summary

4. Market dynamics

4.1 Drivers of growth

4.2 Challenges

5. Global Market and Users of Glucose (SMBG)

5.1 Blood Glucose (Type 1 + Type 2) Diabetes Devices Market

5.1.1 Type 1 diabetes

5.1.2 Type 2 diabetes

5.2 Test Strips Market and Forecast

5.2.1 Type 1 diabetes

5.2.2 Type 2 diabetes

5.3 Lancet Market and Forecast

5.3.1 Type 1 diabetes

5.3.2 Type 2 diabetes

5.4 meter market and forecast

5.4.1 Type 1 diabetes

5.4.2 Type 2 diabetes

5.5 Global Diabetes Population (Type 1 + Type 2)

5.5.1 Population with type 1 diabetes

5.5.2 Population with type 2 diabetes

5.6 Users of blood glucose monitoring devices (SMBG) (Type1 + Type 2)

5.6.1 Type 1 Diabetes Device Users

5.6.2 Users of type 2 diabetes measuring devices

6. Share Analysis – Blood Glucose Devices Market, Diabetic Population, SMBG User

6.1 SMBG Market Share

6.1.1 Total SMBG Market Share

6.1.1.1 Type 1

6.1.1.2 Type 2

6.1.2 Test strips

6.1.2.1 Type 1

6.1.2.2 Type 2

6.1.3 Lancet

6.1.3.1 Type 1

6.1.3.2 Type 2

6.1.4 Blood glucose meter

6.1.4.1 Type 1

6.1.4.2 Type 2

6.1.5 Share of population with diabetes

6.1.5.1 Type 1 diabetes

6.1.5.2 Type 2 diabetes

6.1.6.1 Type 1 diabetes

6.1.6.2 Type 2 diabetes

7. United States

8. UK

9. Germany

ten. Spain

11. Italy

12. Netherlands

13. Norway

14. Sweden

15. Swiss

16. Australia

17. Kuwait

18. Brazil

19. Russia

20. India

21. China

22. South Africa

23. Saudi Arabia

24. Business Analysis

24.1 Roche-Diagnosis

24.1.1 Presentation

24.1.2 Recent Developments

24.1.3 Revenue

24.2 Abbott Laboratories

24.2.1 Presentation

24.2.2 Recent Developments

24.2.3 Revenue

24.3 Dexcom, Inc.

24.3.1 Presentation

24.3.2 Recent Developments

24.3.3 Revenue

24.4 Medtronic

24.4.1 Presentation

24.4.2 Recent Developments

24.4.3 Revenue

24.5B. Braun Melsungen SA

24.5.1 Presentation

24.5.2 Recent Developments

24.5.3 Revenue

24.6 Dario Health Corp

24.6.1 Presentation

24.6.2 Recent Developments

24.6.3 Revenue

For more information about this report visit https://www.researchandmarkets.com/r/glomjp

Media Contact:

Research and Markets

Laura Woodsenior

[email protected]

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907

Fax (outside the US): +353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/global-blood-glucose-device-market-report-2022-to-2027—key-drivers-and-challenges-301546904.html

SOURCE Research and Markets

Share.

About Author

Comments are closed.